Biomedical Engineering: Enhanced Treatment for Cardiac Arrhythmias
The emergence and growth of cardiovascular diseases have become a real threat these days, and Several advanced strategies ranging from advanced hospital devices to wearables has been developed to cope with this problem.
Medtronic plays a pivotal role and has undertaken several important measures to revolutionize the treatment process of cardiovascular ailments. The company has taken a further leap from its competitors introducing MyCareLink Heart to connect users’ smartphones with the company’s portfolio of connected pacemakers. Statista predicts the estimation of the global market of pacemakers will be more than $10 billion by 2023. Amidst this growth of pacemaker users, this innovative pacer-connected app working with BlueSync technology-powered pacemakers to send device data directly to CareLink network without any dedicated bedside monitors will play a vital role in helping the users to deal with the complexities related to pacemakers.
Medtronic has announced that it has signed an agreement to acquire EPIX therapeutics, a unique and innovative medical device manufacturer, with an aim to empower healthcare providers with comprehensive tools to combat cardiac arrhythmias. The DiamondTemp ablation system from EPIX Therapeutics is an innovative temperature-controlled system for cardiac ablation that leverages radiofrequency energy for producing scar tissue in the heart and ultimately, helps to separate pulmonary veins complementing Medtronic cryoballoon technology. This ablation system holds the CE Mark in Europe, and will enormously be helpful for patients suffering from symptomatic paroxysmal AF. This DiamondTemp ablation system is a real market leader, as it can control the temperature in real-time through rapid modulation of power. Under this agreement, EPIX's ablation system will be integrated with Medtronic’s cryoballoon technology to squeeze out market-leading cryo and RF systems.
Check this out: Top Healthcare Tech Companies
The arctic front advance cryoablation system has an important role in the isolation process of the pulmonary veins which spread erratic electrical signals causing AF. Leveraging cryo energy, the device can lead to the creation of scar tissue in order to hinder the irregular electrical pathways. This innovative cryoablation system has treated more than 500,000 patients across 60 countries. Medtronic aims at revolutionizing biomedical engineering through innovative products like Cool-tip, the Evident, and the Emprint ablation system. The Cool-tip™ RF Ablation System E Series, a device with simple straight-needle design and improved safety features, is a further improvement on the Cool-tip™ RFA system and allows the measurement and control of tissue temperature during the ablation process.